Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского» Департамента здравоохранения г. Москвы, Москва, Россия; 2 ФГАОУ ВО «Российский университет дружбы народов», Москва, Россия; 3 АНО «Международное общество "Стресс под контролем"», Москва, Россия ol_kotova@mail.ru
Список исп. литературыСкрыть список 1. Linaker C, Harris EC, Cooper C et al. The burden of sickness absence from musculoskeletal causes in Great Britain. Occup Med 2011; 61: 458–64. DOI: 10.1093/occmed/kqr061 2. Bevan S. Economic impact of musculoskeletal disorders (MSDs) on work in Europe. Best Pract Res Clin Rheumatol 2015; 29: 356–73. DOI: 10.1016/j.berh.2015.08.002 3. Delitto A, George SZ, Van Dillen LR et al. Low back pain: clinical practice guidelines linked to the International Classification of Functioning. J Ortho Sports Phys Ther 2012; 42: A1–57. 4. Smuck M, Kao MC, Brar N et al. Does physical activity influence the relationship between low back pain and obesity? Spine 2014; 14: 209–16. 5. Verkerk K, Luijsterburg PA, Heymans MW et al. Prognosis and course of disability on patients with chronic nonspecific low back pain: A 5 and 12-month follow-up cohort study. Phys Ther 2013; 93: 1603–14. 6. DeMarco MA, Maynard JW, Huizinga MM et al. Obesity and younger age at gout onset in a community-based cohort. Arthr Care Res (Hoboken) 2011; 63: 1108–14. 7. Mezhov V, Ciccutini FM, Hanna FS et al. Does obesity affect knee cartilage? A systematic review of magnetic resonance imaging data. Obes Rev 2014; 15: 143–57. 8. Issa RI, Griffin TM. Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation. Pathobiol Aging Age Dis 2012; 2: 17470. 9. Stienstra R, Duval C, Müller M, Kersten S. PPARs, obesity, and inflammation. PPAR Res 2007; 2007: 95974. 10. Shiri R, Viikari-Juntura E, Varonen H, Heliovaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol 2006; 164: 1065–74. 11. Zhang Y, Zhang S, Gao Y et al. Factors associated with the pressure pain threshold in healthy Chinese men. Pain Med 2013; 14: 1291–300. 12. Ackermann K, Revell VL, Lao O, Rombouts EJ et al. Diurnal rhythms in blood cell populations and the effect of acute sleep deprivation in healthy young men. Sleep 2012; 35: 933–40. 13. Thamaraiselvi K, Mathangi DC, Subhashini AS. Effect of increase in duration of rem sleep deprivation on lipid peroxidation. Int J Biol Med Res 2012; 3: 1754–9. 14. Galletly CA, Foley DL, Waterreus A et al. Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis. Aust NZ J Psychiatr 2012; 46: 753–61. 15. Котова О.В., Акарачкова Е.С. Кеторолак: применение, эффективность, безопасность. Неврология и ревматология. Прил. к журн. Consilium Medicum. 2016; 1: 70–3. [Kotova O.V., Akarachkova E.S. Ketorolak: primenenie, effektivnost', bezopasnost'. Nevrologiia i revmatologiia. Pril. k zhurn. Consilium Medicum. 2016; 1: 70–3 (in Russian).] 16. Котова О.В., Акарачкова Е.С. Нежелательные явления нестероидных противовоспалительных препаратов: возможные варианты выхода из ситуации. Consilium Medicum. 2017; 2.2: 85–90. [Kotova O.V., Akarachkova E.S. Nezhelatel'nye iavleniia nesteroidnykh protivovospalitel'nykh preparatov: vozmozhnye varianty vykhoda iz situatsii. Consilium Medicum. 2017; 2.2: 85–90 (in Russian).] 17. Geller M, Mibielli MA, Nunes CP et al. Comparison of the action of diclofenac alone versus diclofenac plus B vitamins on mobility in patients with low back pain. J Drug Assess 2016; 5 (1): 1–3. eCollection 2016. 18. Mibielli MA, Geller M, Cohen JC et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: The DOLOR study. Curr Med Res Opin 2009; 25: 2589–99. 19. Franceschi F, Saviano L, Petruzziello C et al. Safety and efficacy of low doses of diclofenac on acute pain in the emergency setting. Eur Rev Med Pharmacol Sci 2015; 20: 4401–8. 20. Suzuki K, Tanaka H, Ebara M et al. Electrospun nanofiber sheets incorporating methylcobalamin promote nerve regeneration and functional recovery in a rat sciatic nerve crush injury model. Acta Biomater 2017; 53: 250–9. 21. Hong L, Zhang J, Shen J. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy. J Diabet Complicat 2015; 29:1283–6. 22. Chen M, Peyrin-Biroulet L, George A et al. Methyl deficient diet aggravates experimental colitis in rats. J Cell Mol Med 2011; 15: 2486–97. 23. Erfanparast A, Escort M, Tamaddonfard E et al. Systemic and local peripheral injections of vitamin B12 suppressed orofacial nociception induced by formalin in rats. Drug Res 2014; 64: 85–90. 24. Padi SSV, Naidu PS, Kulkarni SK. Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats. Inflammopharmacology 2006; 14: 57–61. 25. Hosseinzadeh H, Moallem SA, Moshiri M et al. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice. Arzneimittelforschung 2012; 62: 324–9. 26. Mauro GL, Martorana U, Cataldo P et al. Vitamin B12 in low back pain: A randomised, double-blind, placebo-controlled study. Eur Rev Med Pharmacol Sci 2000; 4: 53–8. 27. Reyes-Garcia G, Medina-Santillan R, TeranRosales F et al. Characterization of the potentiation of the antinociceptive effect of diclofenac by vitamin B complex in the rat. J Pharmacol Toxicol Methods 42: 73–77. 28. Franca DS, Souza A L, Almeida KR et al B vitamins induce an antinociceptive effect in the acetic acid and formaldehyde models of nociception in mice. Eur J Pharmacol 2001; 421: 157–164. 29. Moallem SA, Hosseinzadeh H, Farahi S. A Study of Acute and Chronic Anti-Nociceptive and Anti-Inflammatory Effects of Thiamine in Mice. IBJ 2008; 12 (3): 173–8. 30. Беляев А.А., Котова О.В., Акарачкова Е.С. Кардиальная автономная невропатия у больных сахарным диабетом. Медицинский совет. 2019; 1: 52–6. [Beliaev A.A., Kotova O.V., Akarachkova E.S. Kardial'naia avtonomnaia nevropatiia u bol'nykh sakharnym diabetom. Meditsinskii sovet. 2019; 1: 52–6 (in Russian).] 31. Котова О.В., Акарачкова Е.С., Беляев А.А. Неврологические осложнения сахарного диабета. Медицинский совет. 2019; 9: 40–4. [Kotova O.V., Akarachkova E.S., Beliaev A.A. Nevrologicheskie oslozhneniia sakharnogo diabeta. Meditsinskii sovet. 2019; 9: 40–4 (in Russian).] 32. Котова О.В., Акарачкова Е.С. Диабетическая автономная полинейропатия. Журн. неврологии и психиатрии им. C.C. Корсакова. 2017; 117 (2): 169–73. [Kotova O.V., Akarachkova E.S. Diabeticheskaia avtonomnaia polineiropatiia. Zhurn. nevrologii i psikhiatrii im. C.C. Korsakova. 2017; 117 (2): 169–73 (in Russian).] 33. Котова О.В. Диабетическая автономная полиневропатия. Фарматека. 2012; 6: 40–4. [Kotova O.V. Diabeticheskaia avtonomnaia polinevropatiia. Farmateka. 2012; 6: 40–4 (in Russian).]